Less than one in 20 children had symptoms for more than four weeks
News
UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours
Sativex is a complex botanical formulation that contains the principal cannabinoids THC and CBD
MHRA approves Opdivo plus Yervoy for unresectable malignant pleural mesothelioma
First treatment to be approved for UK MPM patients for more than 15 years
CMA fines Advanz over ‘excessive and unfair’ pricing of thyroid drug
The £100m fine sends ‘a clear message’ to the pharma sector, said the CMA
Tecentriq wins FDA priority review for certain early NSCLC patients
Tecentriq is first and only cancer immunotherapy with positive Phase III results in adjuvant lung cancer setting
Gov’t launches study on COVID-19 vaccine dose interval for pregnant women
The study will be the largest clinical trial of its kind in the UK, involving over 600 pregnant women
Sanofi boosts its mRNA capabilities with Translate Bio acquisition
Sanofi will acquire Translate Bio for approximately $3.2bn, or $38.00 per share in cash
EC approves BMS’ Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients
The approval is based on Phase III results from the CheckMate-577 trial
AZ’s Saphnelo scores US approval for systemic lupus erythematosus
Saphnelo is the first type I interferon receptor agonist to receive regulatory approval
UCB’s bimekizumab issued NICE recommendation for severe plaque psoriasis
Bimekizumab is the first to follow NICE’s new expedited appraisal process
More than 85 million COVID vaccines administered across the UK, reports DHSC
Over 88% of adults have had a first dose and over 72% both doses
GSK’s Nucala approved to treat chronic rhinosinusitis with nasal polyps
Nucala is the first IL-5 inhibitor to be approved for adult CRSwNP patients in the US
NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab
Although condition is extremely rare, it requires ‘swift diagnosis and urgent treatment’ says NICE
UK genomics market valued at over £5bn, according to new report
‘Genomics Nation’ report launched in a bid to showcase the thriving UK genomics sector
GPs call for rescue plan to ‘save’ general practice in the UK
RCGP’s chair said that general practice in the UK is currently at a ‘breaking point’
